Concord Biotech Ltd. IPO

The company is a leading India-based biopharma company specializing in fermentation-based APIs for immunosuppressants and oncology. With a significant global market share, the company supply to over 70 countries, including regulated markets. Its sustainable manufacturing capabilities and focus on therapeutic areas like immunology and oncology drive its success in the dynamic biopharma industry.

RHP
View
DRHP
View
Open Date

2023-08-04

Close Date

2023-08-08

Concord Biotech Ltd. IPO Details

Check out the issue details for Concord Biotech Ltd. IPO as disclosed in SEBI.

IPO Price

₹ 741

Price Band

₹ 705 - 741

Issue Size

1551 Cr.

Issue Type

Book Built

Open

2023-08-04

Close

2023-08-08

Listingprice

₹ 900.05

ListingGain

21.46%

Listing Date

2023-08-18

CMP

₹ 1991.2

Current Return

168.72%

Concord Biotech Ltd. News

Concord Biotech informs about earnings call transcript19 Nov, 12:26PM Concord Biotech - Quaterly Results11 Nov, 1:08PM Concord Biotech - Quaterly Results11 Nov, 1:08PM Concord Biotech - Quaterly Results11 Nov, 1:08PM Concord Biotech informs about board meeting6 Nov, 11:01AM Concord Biotech informs about earnings call 6 Nov, 10:57AM Concord Biotech informs about closure of trading window 25 Sep, 4:56PM Concord Biotech informs about clarification on price movement 24 Sep, 2:58PM Concord Biotec informs about investor meeting 30 Aug, 12:09PM Concord Biotech - Quaterly Results9 Aug, 1:41PM Concord Biotech - Quaterly Results9 Aug, 1:41PM Concord Biotech - Quaterly Results9 Aug, 1:41PM Concord Biotech informs about voting results and scrutinizer report 2 Jul, 11:10AM Concord Biotech informs about annual report 1 Jul, 2:41PM Health Product Regulatory Authority issues EUGMP certificate to Concord Biotech’s Valthera facility6 Jun, 12:27PM Concord Biotech informs about earnings call transcript4 Jun, 5:11PM Concord Biotech informs about disclosures 29 May, 4:20PM Concord Biotech - Quaterly Results23 May, 3:36PM Concord Biotech - Quaterly Results23 May, 3:36PM Concord Biotech - Quaterly Results23 May, 3:36PM

Company Financials

You can get the following financial statements of Concord Biotech Ltd. as of now.

Company Name

Concord Biotech Ltd.

Exchange

NSE: CONCORDBIO BSE: 543960

  Profit Loss
  Balance Sheet
  Quarterly
  Shareholding
  Cash Flow

The details about the Concord Biotech IPO is as:

  • The issue size of the Concord Biotech IPO is 1551 Cr.
  • The price band for Concord Biotech IPO is Rs 705 to Rs 741.
  • The shares of Concord Biotech IPO will list on 18th August 2023.
  • The latest tentative GMP of Concord Biotech IPO is Rs 150.
  • The shares of Concord Biotech IPO is subscribed 24.87 Times as of 8th August 2023.

 

Concord Biotech IPO Valuation

The approx valuation of Concord Biotech IPO based on its price band and RHP/DRHP (prospectus) is:

Particulars Value
Upper Price Band Rs 741
Existing Shares (Qty) 10.46 Cr
Market Cap 7750.86 Cr
EPS (FY23) Rs 22.95
PE Ratio 32.28x
Industry PE 35.98x

 

Concord Biotech IPO Issue Size

Concord Biotech IPO issue size is 1551 Cr.

Issue Amount
Fresh Issue 0 Cr
Offer For Sale 1551 Cr

 

Concord Biotech IPO Market Lot

An Individual can apply for a minimum 1 lot of 20 shares and a maximum of 13 lots of 260 shares. Find the details below:

Application Lot Shares Amount
 Minimum  1 20 Rs 14,820
 Maximum 13 260 Rs 1,92,660

 

Concord Biotech IPO Offer

The shares of Concord Biotech IPO is subscribed 24.87 Times as of 8th August 2023. The category-wise shares subscribed are as follows:

Category % Offered Subscription
Qualified Institutional Maximum 50% 67.67 Times
Non-Institutional Minimum 15% 16.99 Times
Retail Individual Minimum 35% 3.78 Times
Employee 10000 Shares 24.48 Times
Total   24.87 Times

 

Concord Biotech IPO Grey Market Premium

As on GMP (Tentative)
6 August 2023 Rs 150
7 August 2023 Rs 200
8  August 2023 Rs 160
9 August 2023 Rs 140
10 August 2023 Rs 160
13  August 2023 Rs 160
14  August 2023 Rs 150

Concord Biotech IPO GMP is purely for informational purposes and invest in an IPO after thoroughly researching on your own.

Find below the dates for Concord Biotech Ltd IPO: 

Schedule Date
Basis of Allotment 11 August 2023
Refunds 14 August 2023
Credit to Demat Account 17 August 2023
IPO Listing Date 18 August 2023

Check allotment status

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 512.33 616.94 712.93 853.17 1016.94
Total Expenditure 307.79 289.01 439.01 504.59 584.75
Operating Profit 204.54 327.93 273.93 348.58 432.19
Other Income 31.37 13.81 23.42 35.31 33.78
Interest 1.17 1.05 6.13 9.8 3.18
Depreciation 21.25 27.52 50.05 54.03 53.59
Exceptional Items 0 0 0 0 0
Profit Before Tax 213.49 313.17 241.16 320.05 409.19
Provision for Tax 44.53 77.83 62.59 81.93 104.46
Net Profit 168.96 235.29 178.57 238.13 304.73
Adjusted EPS (Rs.) 1.62 2.25 1.71 2.28 2.91

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 9.51 9.51 9.51 10.46 10.46
Total Reserves 760.57 990.16 1097.65 1281.52 1514.79
Borrowings 35.53 56.25 31.25 6.24 0
Other N/C liabilities 19.66 151.37 212.23 25.9 31.91
Current liabilities 223.27 105.74 151.89 190.53 142.16
Total Liabilities 1048.54 1313.03 1502.53 1514.65 1699.32
Assets
Net Block 239.6 546.22 572.98 592.98 575.32
Capital WIP 141.4 17.95 74.16 172.7 211.48
Intangible WIP 0 0 0 0 0
Investments 0.67 0.67 0.92 0.79 0.67
Loans & Advances 19.44 140.61 220.99 11.61 12.81
Other N/C Assets 0.67 0.45 0.82 8.87 2.81
Current Assets 646.76 607.15 632.67 727.7 896.23
Total Assets 1048.54 1313.03 1502.53 1514.65 1699.32
* Other Non-current Liabilities include Net deferred Liabilities

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Other Income 8.13 8.19 10.81 10.31 10.03
Profit Before Tax 113.18 100.09 130.92 78.17 133.29
Tax 28.69 25.53 33.7 19.93 34.59
Profit After Tax 84.49 74.55 97.22 58.24 98.7
Adjusted EPS (Rs) 8.08 7.13 9.29 5.57 9.43

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 44.08 0
Jun 2024 44.08 0
Mar 2024 44.08 0
Dec 2023 44.08 0
Sep 2023 44.08 0
* Figures given above are % of equity capital

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 213.49 313.17 241.16 320.05 409.19
Adjustment 12.27 17.59 49.16 48.51 40.8
Changes in Assets & Liabilities -21.85 -88.77 -22.06 -52.29 -81.18
Tax Paid -49.1 -75.18 -60.78 -70.28 -103.35
Operating Cash Flow 154.81 166.81 207.47 246 265.47
Investing Cash Flow -112.74 -195.2 -111.79 -157.95 -154.61
Financing Cash Flow -43.41 31.12 -100.16 -85.22 -99.21
Net Cash Flow -1.35 2.74 -4.48 2.83 11.64
X